| 000 | 01068 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250518004832.0 | ||
| 264 | 0 | _c20191014 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a1179-1934 | ||
| 024 | 7 |
_a10.1007/s40263-018-0582-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGust, Juliane | |
| 245 | 0 | 0 |
_aNeurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies. _h[electronic resource] |
| 260 |
_bCNS drugs _c12 2018 |
||
| 300 |
_a1091-1101 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntigens, CD19 _xmetabolism |
| 650 | 0 | 4 |
_aCytokines _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aImmunotherapy, Adoptive _xmethods |
| 650 | 0 | 4 |
_aNeurotoxicity Syndromes _xepidemiology |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xmetabolism |
| 700 | 1 | _aTaraseviciute, Agne | |
| 700 | 1 | _aTurtle, Cameron J | |
| 773 | 0 |
_tCNS drugs _gvol. 32 _gno. 12 _gp. 1091-1101 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40263-018-0582-9 _zAvailable from publisher's website |
| 999 |
_c29003567 _d29003567 |
||